Copyright
©The Author(s) 2016.
World J Clin Oncol. Apr 10, 2016; 7(2): 160-173
Published online Apr 10, 2016. doi: 10.5306/wjco.v7.i2.160
Published online Apr 10, 2016. doi: 10.5306/wjco.v7.i2.160
Figure 1 Prevalence of estrogen receptor alpha gene amplification in the literature.
The fraction of altered cases (y-axis) is indicated across published studies (x-axis) and is shown separately for different detection methods. The studies are sorted in descending order of ESR1 amplification frequency, as detected. A: Prevalence of ESR1 amplification defined according to the diagnostic criteria for ERBB2 (HER2) amplification; B: Prevalence of ESR1 copy number increase including amplification and gain. For study citations see Appendices A-D. ESR1: Estrogen receptor alpha gene; MLPA: Multiplex ligation-dependent probe amplification; FISH: Fluorescence in situ hybridization; CISH: Chromogenic in situ hybridization.
- Citation: Holst F. Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate. World J Clin Oncol 2016; 7(2): 160-173
- URL: https://www.wjgnet.com/2218-4333/full/v7/i2/160.htm
- DOI: https://dx.doi.org/10.5306/wjco.v7.i2.160